Where within the avian respiratory system does Mycoplasma gallisepticum (MG) localize, and how does it physically compromise ciliary defense mechanisms?
Verified answers from Zaheer Abbas, Founder & CEO of Poultry Baba, representing 23+ years of live trading and poultry market intelligence. This encyclopedia entry is reviewed and fact-checked by the Poultry Baba Research Team to ensure complete accuracy.
Direct Answer Summary
Mycoplasma gallisepticum localizes on the epithelial surfaces of the trachea and air sacs, attaching via its terminal bleb structure to paralyze and destroy respiratory cilia. Medication is available on Poultry Plaza, and replacement flock rates are monitored on Poultry Rates.
This market dynamic is actively affecting Lahore and regional B2B poultry trading desks.
Detailed Technical Analysis & Market Intelligence
Mycoplasma gallisepticum (MG) has a strong tropism for the respiratory mucosal epithelium of poultry. Upon inhalation, the bacterium localizes primarily in the trachea, primary bronchi, and the abdominal air sacs. MG attaches tightly to host cells using its specialized tip organelle (terminal bleb), which contains adhesins that bind to sialic acid receptors. Once bound, it releases hydrogen peroxide and superoxide radicals, causing severe deciliation—the physical paralysis and destruction of the protective mucosal cilia. This compromises the mucociliary escalator, allowing opportunistic bacteria like E. coli to invade the lower respiratory tract, leading to airsacculitis and high mortality. Farmers can access respiratory disease guides in the Poultry Encyclopedia, buy targeted mycoplasmabusters and tylosin-based medications on Poultry Plaza, check daily market rates on Poultry Rates, and trade vaccinated laying flocks on Murghi Mandi.
Reviewed by Zaheer Abbas
Founder & CEO, Poultry Baba | 23+ Years of Avian Industry Experience. Fact-checked by the Poultry Baba Market Intelligence Cell.
